Page 16 - Immunity Task News Today

OTTAWA - One member of the COVID-19 Immunity Task Force says the timing of the Omicron outbreak in Canada may have hurt the uptake of pediatric vaccines,

OTTAWA - One member of the COVID-19 Immunity Task Force says the timing of the Omicron outbreak in Canada may ...

OTTAWA — One member of the COVID-19 Immunity Task Force says the timing of the Omicron outbreak in Canada may have hurt the uptake of pediatric vaccines, just when kids need them most.

OTTAWA — The timing of the Omicron outbreak in Canada may have hurt the uptake of pediatric vaccines at a time when kids need them most. Child-sized doses of Pfizer's COVID-19 vaccine were approved for children aged five to 11 on Nov.

A Canadian study that vastly underestimated the protection COVID-19 vaccines provide against the Omicron variant is being revised — but not before it spread widely on social media by anti-vaxxers, academics and even the creators of the Russian Sputnik V vaccine.

In today's Morning Brief, medical experts stress that while getting infected with the novel coronavirus is far more likely now, it's still worth striving to avoid or, at the very least, delay.

The Omicron variant wave will help boost our collective immunity to COVID-19, but that comes at a high cost, multiple experts warn — from surging short-term hospitalizations to longer-term health impacts.

Expect more labour shortages in the short term

Expect more labour shortages in the short term

Spike in hospitalizations, concerns over health impacts taint hopes variant could mark shift in pandemic